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Capsule summary: Here we show that differentiation of human naïve CD4 T-cells to 29 
Th2 is promoted by Hedgehog signaling and attenuated by SMO-inhibition. As 30 
Hedgehog proteins are produced by epithelial tissues this finding is important to 31 
understanding atopic disease. 32 
 33 
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FACS: Fluorescence-activated cell sorting  36 
GLI: Glioma-associated Oncogene 37 
Hh: Hedgehog 38 
IFN-γ: Interferon gamma 39 
PTCH1: PATCHED1 40 
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To the Editor: 45 
Hedgehog (Hh) proteins are inter-cellular signalling molecules that control 46 
development and tissue homeostasis. They also regulate thymocyte development and  47 
peripheral T-cell activation in mouse and human, and have recently been shown to 48 
promote Th2 differentiation and function in mice (1-4).  SHH is involved in 49 
homeostasis of many epithelial tissues, and as these tissues are the sites of allergic 50 
disease, it is important to understand how Hh signalling influences human CD4 T 51 
helper differentiation. Here we show that Hedgehog signalling promotes human Th2 52 
differentiation, using materials and methods described in (3, 5) and the 53 
Supplementary File. 54 
We used quantitative(Q) RT-PCR to evaluate gene expression of components of the 55 
Hh signaling pathway in naive human CD4 T-cells stimulated for 48h in Th0, Th1 or 56 
Th2 polarizing conditions. Expression of the Hh-responsive transcription factors GLI1 57 
and GLI2 and the Hh cell surface receptor PTCH1 were higher in CD4 T-cells 58 
cultured under Th2 skewing conditions, compared to Th0 or Th1 conditions (Fig.1A), 59 
suggesting that Hh signaling is involved in human Th differentiation or function.  As 60 
GLI1 and PTCH1 are Hh-target genes, their higher expression in Th2-differentiated 61 
cells indicates that this population has overall higher Hh-mediated transcription.  62 
To test the influence of SHH signaling on Th differentiation, we stimulated purified 63 
naïve human CD4 T-cells from 12 independent randomly selected anonymous donors 64 
for 4 days under skewing conditions, with or without a single dose of recombinant 65 
Shh (rShh).  Treatment with rShh significantly enhanced expression of the Th2-66 
transcription factor GATA3 in cells stimulated under Th2 conditions, whereas 67 
GATA3 expression in Th0 conditions, and TBET expression in Th0 or Th1 conditions 68 
were not affected (Fig.1B-C). Treatment of Th2-skewing cultures with rShh also 69 
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increased the concentration of IL-4 in supernatants after 4 days of culture, compared 70 
to control Th2-skewing cultures (Fig.1D). Interestingly, the concentration of IFN-γ 71 
was lower when rShh was added compared to control Th1 cultures (Fig.1E).  After 7 72 
days of culture and CD3/CD28 restimulation, the proportion of CD4 T-cells that 73 
expressed IL-4 was significantly increased in the presence of rShh under Th2 74 
conditions (Fig. 1F). In contrast, the percentage of cells that expressed IFN-γ was 75 
reduced in Th1+rShh cultures compared to Th1 cells (Fig. 1G). Shh-treatment 76 
increased GATA3 and IL4 expression in Th2 cultures (Fig.1H), whereas rShh-77 
treatment decreased IFNG and TBX21 (TBET) expression in Th1 cultures (Fig.1I). 78 
These data indicate that Hh signalling promotes Th2 differentiation in human CD4 T-79 
cells, with simultaneous repression of IFN-γ and ΤΒΕΤ.  80 
We then investigated whether pharmacological inhibition of the Hh signalling 81 
pathway, by treatment with an inhibitor of the non-redundant Hh-signal transduction 82 
molecule SMO (PF-04449913) would impair Th2 differentiation(6). The proportion 83 
of cells that expressed the Th1 lineage-specific transcription factor TBET was not 84 
affected by SMO-inhibitor treatment under skewing conditions (Fig.2A). Likewise, 85 
no differences were found in the expression of GATA3 under neutral or Th1 86 
conditions (Fig.2B).  However, SMO-inhibitor-treatment significantly reduced the 87 
proportion of CD4 T-cells that expressed GATA3 and KI67 (marker of proliferation) 88 
when cultured under Th2 skewing conditions (Fig.2B-C). SMO-inhibition did not 89 
affect the percentage of cells that expressed IFN-γ in Th1 conditions, and as expected 90 
IL-4 expression was low in Th1 conditions in both control and SMO-inhibitor-treated 91 
cultures (Fig.2D). When cultured under Th2- conditions, however, the percentage of 92 
cells that expressed IL-4 was significantly reduced by SMO-inhibitor-treatment 93 
(Fig.2E). Analysis of cytokine concentration in culture supernatants by ELISA 94 
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showed that IFN-γ levels were similar in both groups under Th1 conditions (Fig. 2F), 95 
but under Th2 conditions significantly lower concentrations of IL-4 were found in the 96 
SMO-inhibitor group compared to controls (Fig. 2G). Finally, we investigated the 97 
transcript levels of IL4 and IFNG by QRT-PCR.  In Th2 skewed cells IL4 expression 98 
was significantly lower in SMO-inhibitor-treated cultures than controls (Fig. 2H), 99 
whereas IFNG transcript levels were not different between groups under Th1 100 
conditions (Fig. 2I). Taken together, these analyses indicated that attenuation of Hh 101 
signal transduction by treatment with the SMO-inhibitor reduced Th2 differentiation, 102 
but did not affect Th1 fate. 103 
Here we show that Hedgehog signalling promotes Th2 differentiation in human CD4 104 
T-cells. We found that treatment of naïve CD4 T-cells with rShh under Th2 skewing 105 
conditions increased the expression of the transcription factor GATA3, a reliable 106 
indicator of Th2 transcriptional identity.  In support of this, IL4 expression was 107 
enhanced and IL-4 cytokine production was increased in Th2 cultures on treatment 108 
with rShh. In contrast, rShh treatment antagonised Th1 differentiation in Th1 cultures, 109 
leading to lower IFNG and TBX21 expression and a lower proportion of cells 110 
expressing intracellular IFN-γ. Attenuation of Hh signal transduction by 111 
pharmacological SMO-inhibition reduced Th2 differentiation: both GATA3 and IL4 112 
expression were significantly decreased.   113 
In murine T helper differentiation, Hh signalling promotes Th2 differentiation, 114 
skewing the overall pattern of transcription to a Th2-like profile, and Il4 is a Gli2 115 
target gene in murine T-cells(3). Importantly, Hh pathway activation in T-cells has 116 
physiological relevance in a murine model of allergic asthma, as by favouring Th2 117 
polarization and cytokine production, it contributes to disease severity (3, 7).  118 
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In humans, GWAS linked components of the Hedgehog (Hh) signalling pathway to 119 
allergic asthma (8), and a recent study found that children with asthma presented with 120 
higher levels of SHH in airway epithelia than healthy controls (9).  121 
Here we provide in vitro evidence that Hedgehog signalling enhances Th2 122 
differentiation in human CD4 T-cells. One strength of our study is that our 123 
experiments were performed using cells isolated from 12 different unknown leucocyte 124 
cone donors, and we obtained consistent experimental results from all donors, 125 
independent of their age or gender (of which we had no knowledge).  A weakness of 126 
our study is that it was limited to in vitro experimentation.  In the future it will 127 
therefore be interesting to assess the Th differentiation status of T-cell populations 128 
isolated from patient samples from sufferers of asthma to obtain further ex vivo 129 
evidence that Hh signalling is involved in human Th2 responses.  This will be 130 
important to our understanding of human atopic disease such as asthma, in which Th2 131 
T-cell responses drive disease. 132 
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Figure Legend 177 
Figure 1. Shh treatment increases Th2 differentiation in vitro 178 
Naïve CD4 T-cells (n=12 donors) stimulated under Th-skewing conditions, +/-rShh 179 
(B-I); analysed at 48h (A), day4 (B-E) and day7+restimulation (F-I). Plots: 180 
mean±SEM; each point represents an individual donor. (A) Gene expression (QRT-181 
PCR) (n=3). (B-C) FACS-histograms show intracellular-expression (gated on CD4+) 182 
of (B) GATA3; (C) TBET. Grey-overlays: control stain. Scatter-plots: percentage of 183 
positive cells. (D-E) Cytokine concentration (ELISA) in supernatants. (F-G) FACS-184 
plots: CD4 and intracellular-cytokine expression. Scatter-plots: percentage cytokine-185 
positive. (H-I) Gene expression (QRT-PCR, n=3).  Paired 2-tailed t-test; *p<0.05; ** 186 
p<0.01. 187 
Figure 2. SMO-inhibition decreases Th2 differentiation in vitro. 188 
Naïve CD4 T-cells (n=12 donors) stimulated under Th-skewing conditions with 189 
SMO-inhibitor (grey-fill) or DMSO (control; open bars/squares), on day4 (A-C, F-G) 190 
and day7+restimulation (D-E, H-I). Scatter-plots: mean±SEM; each point represents 191 
an individual donor.   192 
(A-C) Percentage of CD4+ cells that were positive for intracellular staining against 193 
(A) TBET (B) GATA3 and (C) KI67. (D-E) FACS-plots show expression of CD4 194 
and intracellular IFN-γ (upper-plots) or intracellular IL-4 (lower-plots) in cells 195 
cultured in Th1(D) or Th2(E) conditions. Scatter plots show the percentage of CD4+ 196 
cells that stained positive with the stated cytokine. (F-G) Cytokine concentration 197 
(ELISA) in supernatants from Th1(F) and Th2(G) cultures. (H-I) Gene expression 198 
(QRT-PCR)  in cells from Th2(H) and Th1(I) cultures (3 random donors). Paired 2-199 
tailed t-test; *p<0.05; ** p<0.01; ***p<0.001. 200 
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Material and Methods 
Human naïve CD4 purification and culture 
Human peripheral blood mononuclear cells (PBMCs) were freshly isolated from 
randomly-selected unknown leucocyte-cone donors (UK NHS Blood and Transplant 
Centre) by gradient centrifugation using Lymphoprep (Axis-Shield; Olso, Norway). 
The donors to the UK NHS Blood and Transplant Centre are aged between 17 and 65 
years old and we had no knowledge of their age, gender or identity.  Ethical approved 
was authorized by local area NHS REC (research ethics committee).  Naïve CD4 T-
cells (CD3+CD4+CD45RA+CD45RO-) were magnetic-bead purified from PBMC 
using EasySep Isolation Kit (StemCell). Purity of naïve CD4 T-cells was analysed by 
flow cytometry and exceeded 95%.  After magnetic-bead isolation, naive CD4 T-cells 
were rested for 3-5 hours and then plated in 96 round well plates at 1x106 cells/ml. 
Cells were stimulated in complete RPMI (supplemented with 10%FBS, 1% penicilin-
streptomycin and 10-5M 2-mercaptoethanol) with 5µg/ml plate-bound anti-CD3 
antibody (clone UCHT1) and anti-CD28 antibody (eBioscience). For Th0 conditions 
no cytokines were added; For Th1: anti-IL-4 (5µg/ml), rIL-12 (20ng/ml), rIFN-γ 
(10ng/ml); and for Th2: anti-IFNγ (2.5µg/ml), rIL-4 (20ng/ml) were added. After 4 
days, cells were expanded in human rIL-2 (100U/mL) for 3 days in fresh medium 
containing the same skewing cytokines and neutralising antibodies but in the absence 
of anti-CD3 and CD28 stimulation.  Cells were then restimulated for 16 hours by 
addition of soluble anti-CD3 and anti-CD28 (1µg/ml) prior to gene expression and 
cytokine analysis.  Where stated, recombinant Shh (rShh) (R&D Systems) was added 
at a final concentration of 0.5µg/ml at the initiation of culture, and again on day 4 
when the medium was changed and the cells expanded by addition of rIL2.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Where stated, SMO-inhibitor (PF-04449913; Pfizer, dissolved in DMSO) was added 
to cultures for a final concentration of 1nM/ml; (1µl/ml) and an equivalent 
volume/concentration of DMSO alone was added to control wells (DMSO at 1:10,000 
final dilution). This treatment or control was added to the corresponding wells every 
day until the end of the experiment.   
For intracellular (ic) cytokine staining, CD4 T-cells were stimulated for 4 h with 50 
ng/ml PMA (Sigma-Aldrich), 500ng/ml ionomycin (Sigma- Aldrich), and 3µg/ml 
Brefeldin A (eBioscience).  
Flow cytometry 
Cells were stained using combinations of directly conjugated antibodies from 
Thermo Fisher or Biolegend in FACS buffer (5% Fetal Bovine serum  and 0.01% 
sodium azide in 1X PBS), acquired on a C6 Accuri flow cytometer (BD 
Biosciences) and analyzed using FlowJo v10.6. For intracellular staining, CD4 T-
cells were stained with anti-CD4 for cell-surface staining and then incubated with 
Fixation/Permeabilization solution (eBioscience) for 20 minutes in the dark. 
Following this, cells were washed twice with permeabilization buffer then stained 
with specific antibodies in permeabilization buffer for 40 minutes. After 
incubation, cells were washed with permeabilization buffer and resuspended in 
FACS buffer for FACS analysis.  
ELISA  
IFN-γ and IL-4 cytokines were measured using Ready-Set-Go! Kits (eBioscience), 
according to the manufacturer’s instructions.  
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Quantitative (Q)RT-PCR  
RNA was extracted using PicoPure kit (Applied Biosystems). cDNA was synthesized 
using High Capacity cDNA reverse transcription kit (Applied Biosystems) and were 
analysed on an iCycler (Bio-Rad Laboratories, Hercules, CA) using SYBR Green 
Supermix (Bio-Rad) following manufacturer’s guidelines. RNA levels obtained from 
each sample were measured relative to the housekeeping gene HPRT. All primers 
were purchased from Qiagen. 
Statistical analysis  
Paired two-tailed student’s t test was used for statistical analysis for comparison of in 
vitro treatments of cells from a given individual.  Probabilities were considered 
significant if p < 0.05(*), p < 0.01(**), and p < 0.001(***).  
 
